Document is current
Any future updates will be listed below
-
Authors
Tarannum, Sanjana https://orcid.org/0000-0003-0576-6278
Leung, Ying-Ying https://orcid.org/0000-0001-8492-6342
Johnson, Sindhu R. https://orcid.org/0000-0003-0591-2976
Widdifield, Jessica https://orcid.org/0000-0002-7464-0460
Strand, Vibeke https://orcid.org/0000-0003-4978-4072
Rochon, Paula
Eder, Lihi https://orcid.org/0000-0002-1473-1715
- License Information
-
More Information
Article History
Accepted: 29 June 2022
First Online: 4 August 2022
Competing interests
: Y.-Y.L. received an honorarium from AbbVie, DKSH, Janssen, Novartis and Pfizer. V.S. has received consultation fees from AbbVie, Amgen Corporation, Arena, Aria, AstraZeneca, BMS, Boehringer Ingelheim, Celltrion, Galapagos, Genentech/Roche, Gilead, GSK, Horizon, Ichnos, Janssen, Lilly, Merck, Novartis, Pfizer, Regeneron, Rheos, Samsung, Sandoz, Sanofi, Sorrento, Sun Pharma, and UCB. L.E. received educational and research grants and consultation fees from AbbVie, UCB, Eli Lily, Novartis, Sandoz and Pfizer. S.R.J., J.W., S.T. and P.R. declare no competing interests.
